WETENSCHAPPELIJKE OUTPUT THORAXCENTRUM UMCG, 2008



Similar documents
DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

Annual Publication Report

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

Diagnostic and Therapeutic Procedures

Antiaggreganti. STEMI : cosa c è di nuovo? Heartline Genova Novembre 2015

Canadian Journal of Cardiology 27 (2011) Editorial

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Antiplatelet and Antithrombotics From clinical trials to guidelines

California Health and Safety Code, Section

Utilizing the Cath Lab for Cardiac Arrest

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Prognostic impact of uric acid in patients with stable coronary artery disease

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

Aktuelle Literatur aus der Notfallmedizin

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

For the NXT Investigators

Medical Tourism - The Role of Intervals inCardiovascular Cancer

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

Management of Symptomatic Atrial Fibrillation

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Appendix. Costing Case Samples for OOHCA

CARDIOLOGY Delineation of Privileges

MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet

STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY

Antonio Colombo MD on behalf of the SECURITY Investigators

The Cardiac Society of Australia and New Zealand

Imaging of Thoracic Endovascular Stent-Grafts

The 50-year Quest to Replace Warfarin: Novel Anticoagulants Define a New Era. CCRN State of the Heart 2012 June 2, 2012

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν

How to manage a patient who needs thrombolysis in acute stroke, ablation or angioplasty/stenting? Janet M McComb Freeman Hospital Newcastle upon Tyne

Regions Hospital Delineation of Privileges Cardiology

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Emergency Management Strategies for Acute Myocardial Infarction - Code R at LGH

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges

Rivaroxaban for acute coronary syndromes

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

CARDIAC RISKS OF NON CARDIAC SURGERY

Main Effect of Screening for Coronary Artery Disease Using CT

Your Guide to Express Critical Illness Insurance Definitions

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

Treatment of cardiogenic shock

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Press. Siemens solutions support diagnosis and treatment of cardiovascular diseases

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Brief Comparison of Four Agents

ABOUT XARELTO CLINICAL STUDIES

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

LEADING-EDGE Cardiovascular Care

έΰζβν αππ έκυ,νσϊίία κν1γν πλδζέκυνβί1γ π ηία δεόμνκαλ δκζόΰκμ, θν δ υγυθ άμνγνκαλ /εάμ ΚζδθδεάμΝ υλωεζδθδεάμν

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

Triple thérapie anti-thrombotique chez le coronarien. Y Cottin Dijon

Listen to your heart: Good Cardiovascular Health for Life

Electrocardiographic Body Surface Mapping

GENERAL HEART DISEASE KNOW THE FACTS

Perioperative Cardiac Evaluation

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Employee Critical Illness Option

FY2015 Final Hospital Inpatient Rule Summary

Interventional Cardiology Peripheral Interventions Rhythm Management

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

ECG may be indicated for patients with cardiovascular risk factors

The Anti coagulated Patient: The Cardiologist s View. February 28, 2015

ACLS Provider Manual Comparison Sheet Based on 2010 AHA Guidelines for CPR and ECC. BLS Changes

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Samir B. Pancholy, MD, FACC, FSCAI

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Transcription:

WETENSCHAPPELIJKE OUTPUT THORAXCENTRUM UMCG, 2008 Dissertaties 1. Geluk CA Coronary risk stratification. From PREVEND to the prevention of coronary events. ISBN: 978-90-367-3258-1 Promotiedatum: 16 januari 2008 Prof.dr. W.H. van Gilst Prof.dr. J.L. Hillege 2. Dieperink W Multiple applications of the Boussignac continuous positive airway pressure system. ISBN: 978-90-367-4163-8 Promotiedatum: 20 februari 2008 Prof.dr. L.P.H.J. Aarts Copromotores: Dr. M.W.N. Nijsten Mw.Dr. T. Jaarsma 3. Smit JJJ Platelets and White Blood Cells in Acute Coronary Syndromes ISBN: 978-90-9022834-1 Promotiedatum: 23 april 2008 Promotor: Copromotores: Dr. A.W. van t Hof Dr. J.P. Ottervanger 4. Vogelzang M Computer assisted decision support in acutely ill patients. Application in glucose management and quantification of myocardial reperfusion ISBN: 978-90-367-3373-1 Promotiedatum: 21 mei 2008 Promotor: Copromotor: Dr. M.W.N. Nijsten 5. Nienhuis MB Prognostic implications of myocardial injury around percutaneous coronary interventions ISBN: 978-90-367-3416-5 ISBN: 978-90-367-3417-2 (electronic version) Promotiedatum: 28 mei 2008 Prof.dr. H.J.G. Bilo Copromotor: Dr. J.P.Ottervanger 6. Groenewegen HC Therapeutic and mechanistic explorations of in-stent restenosis in the rat aortic stenting model ISBN: 978-90-367-3419-6 ISBN: 978-90-367-3418-9 (digital)

Promotiedatum: 18 juni 2008 Prof.dr. W.H. van Gilst Copromotores: Dr. B.J.G.L. de Smet Dr. A.J.M. Roks 7. Westenbrink BD Erythropoietin in Heart Failure. Pathology and Protection ISBN 978-90-367-3519-3 ISBN 978-90-367-3528-5 (elektronische versie_ Promotiedatum: 17 september 2008 Prof.dr. D.J. van Veldhuisen Copromotores: Prof.dr. W.H. van Gilst Dr. A.A. Voors Dr. R.G. Schoemaker 8. Hartog JWL Advanced glycation end-products in cardiac and renail failure ISBN-13 978-90-75092-51-6 ISBN-13 Digital version 978-90-75092-56-1 Promotiedatum: 3 december 2008 Promotor: Copromotores: Prof.dr. D.J. van Veldhuisen Dr. A.J. Smit Dr. A.A. Voors Dr. S.J.L. Bakker 9. Tan ES Advanced clinical approaches in complex cardiovascular disease. Invasive options at the crossroad of ischemia, heart failure and arrthythmias ISBN-13 978-90-75092-52-3 ISBN-13 978-90-75092-53-0 (digital version) Promotiedatum: 3 december 2008 Prof.dr. I.C. van Gelder Prof.dr. F. Zijlstrs Copromotor: Dr. G.A.J. Jessurun Publicaties Internationale tijdschriften The paramount importance of 12-lead electrocardiography in the management of patients with acute myocardial infarction Catheter Cardiovasc Interv 2008;71:613 Smit JJ, Ottervangfer JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, De Boer MJ,, Van t Hof AW; ON-TIME Study Group Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction Am J Cardiol 2008;101:446-51

Deuling JH, Vermeulen RP, Anthonio RA, Van den Heuvel AF, Jaarsma T, Jessurun G, De Smet BJ, Tan ES, Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression Catheter Cardiovasc Interv 2008;71:518-23 Belonje AM. Voors AA, Van Gilst WH, Anker SD, Slart R.H., Tio RA., Van Veldhuisen DJ; HEBE-III investigators Effects of erythropoietin aftera n acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III) Am Heart J 2008;155:817-22 Groenewegen HC, Onuta G, Goris M, Zandvoort A,, Van Gilst WH, Rozing J, De Smet BJ, Roks AJ, Hillebrands JL Non-bone marrow origin of neointimal smoot muscle cells in experimental in-stent restenosis J Vasc Res 2008;45:493-502 Vlaar PJ, Svilaas T, Van der Horst IC, Diercks GFH, Fokkema ML, De Smet BJGL, Van den Heuvel AFM, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJH, Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study The Lancet 2008;371:1915-20 Vermeulen RP, Jessurun GA, Peels HO, Jaarsma T, Clinical performance indicators for percutaneous coronary intervention Crit Pathw Cardiol 2008;7:126-32 Ruifrok WPT, De Boer RA, Westenbrink BD, Van Veldhuisen DJ, Van Gilst WH Erythropoietin in cardiac disease: new features of an old drug Eur J Pharmacol 2008;585:270-7 Van Gelder IC on behalf of the EHRA Education Committee, Boriani G, Ernst S, Heidbuchel H, Zaza A, Mäkijärvi M, Gorenek B, Blomström Lundquist C Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation Europace 2008;10:77-8 Wiesfeld AC Key questions are helpful to prevent an unnecessary pulmonary veins isolation ablation procedure Europace 2008;10:121; author reply 121 Van Gelder IC, Boriani G, Ernst S, Heidbuchel H, Zaza A, Mäkijärvi M, Gorenek B, Blomström Lundquist C on behalf of the EHRA Education Committee Case of the month by the EHRA Education committee: exercise-related arrhythmias Europace 2008;10:235-7 Buck S, Rienstra M, Maass AH, Nieuwland W, Van Veldhuisen DJ, Van Gelder IC Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time Europace 2008;10:558-65 Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC

New risk factors for atrial fibrillation: causes of not-so-lone atrial fibrillation Europace 2008;10:668-73 Smit AJ, Hartog JWL, Voors AA, Van Veldhuisen DJ Advanced glycation endproducts in chronic heart failure Ann NY Acad Sci 2008:1126:225-230 Van der Meer P, Van Veldhuisen DJ, Januzzi JL Erythropoietin in cardiovascular diseases: exploring new avenues Clinical Science 2008;114:288-91 Dobre D, De Jongste MJL, Haaijer-Ruskamp FM, Sanderman R, Van Veldhuisen DJ, Ranchor AV The enigma of quality of life in patients with heart failure Int J Cardiol 2008;125:407-9 Van der Harst P, Böhm M, Van Gilst WH, Van Veldhuisen DJ The case for statin therapy in chronic heart failure Clin Res Cardiol 2008;97:139-46 Lubbers DD, Willems TP, Van der Vleuten PA, Overbosch J, Götte MJW, Van Veldhuisen DJ, Oudkerk M Assessment of global left ventricular functional parameters: analysis of every second shortaxis magnetic resonance imaging slices is as accurate as analysis of consecutive slices Int J Cardiovasc Imaging 2008;24:185-191 Svilaas T, Vlaar PJJ, Van der Horst ICC, Diercks GFH, De Smet BJGL, Van den Heuvel AFM, Anthonio RL, Jessurun GAJ, Tan, ES, Suurmeijer AJH, Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 2008;358:557-67 Peels HO, Jessurun GAJ, Van der Horst ICC, Arnold AER, Piers LH, Outcome in transferred and nontransferred patients after primary percutaneous coronary intervention for ischaemic out-of-hospital cardiac arrest Catheter Cardiovasc Interv 2008;71:147-51 Hirsch A, Nijveldt R, Van der Vleuten P, Tio RA, Van der Giessen WJ, Marques KMJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WRM, Biemand BJ, Tijssen, JGP, Van Rossum AC, Piek JJ, Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: pilot study of the multicenter HEBE trial Catheter Cardiovasc Interv 2008:71:273-81 Stoel MG, Marques KMJ, De Cock CC, Bronzwaer JG, Von Birgelen C, High dose adenosine for suboptimal myocardial reperfusion after primary PCI: 1 randomized placebo-controlled pilot study Catheter Cardiovasc Interv 2008;71:283-9 Nienhuis MB, Ottervanger JP, Bilo HJG, Dikkeschei BD, Prognostic value of troponin after elective percutaneous coronary intervention. A metaanalysis. Catheter Cardiovasc Interv 2008;71:318-24

Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst ICC, Slart RH, Reiffers S, Dierckx RA, Tio RA, Ottervanger JP, De Boer MJ, The importance of left ventricular function in long-term prognosis after primary percutaneous coronary intervention BMC Cardiovasc Disord 2008;8:4 Van der Harst P, Groenewegen HC, Roks AJ, Buikema H,, Van Gilst WH, De Smet BLGL Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat Coron Artery Dis 2008;19:47-53 Peels JOJ, Anthonio RL, Jessurun GAJ, Mechanical intervention after thrombolysis J Cardiovasc Med 2008;9:15-21 Should we revascularize patients with moderate coronary lesions and borderline fractional flow reserve measurements? Editorial comment Catheter Cardiovasc Interv 2008;71:549-50 How to remove thrombus prior to stenting in patients with acute myocardial infarction? Catheter Cardiovasc Interv 2008;72:204 A novel delta-protein-kinase inhibitor for adjunctive therapy during percutaneous coronary intervention Nat Clin Pract Cardiovasc Med 2008;5:446-7 Dikkers R, Willems TP, Piers LH, De Jonge GJ, Tio RA, Van der Zaag-Loonen HJ, Van Ooijen PM,, Oudkerk M Coronary revascularization treatment base don dual-source computed tomography Eur Radiol 2008;18:1800-8 Vlaar PJ, Diercks GF, Svilaas T, Vogelzang M, De Smet BJ, Van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, The feasibility and safety of routine thrombus aspiration in patients with non-stelevation myocardial infarction Catheter Cardiovasc Interv 2008;72:937-42 Aalbers JJJ, Waterbolk TW, Van Tintelen JP, Hillege, Boonstra PW, Van den Berg MP Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years experience with a protocol based on body surface area Eur J Cardio-thorac Surgery 2008;34:589-94 Buck S, Maass AH, Nieuwland W, Anthonio RL, Van Veldhuisen DJ, Van Gelder IC Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy Eurospace 2008;10:1313-9 Radauceanu A, Ducki C, Virion JM, Rossignol P, Mallat Z, McMurray J, Van Veldhuisen DJ,

Tavazzi L, Mann DL, Capiaumont-Vin J, Li M, Hanriot D, Zannad F Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure J Cardiac Failure 2008;14:467-74 Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW,, Birgersdotter-green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, for the PREPARE Study Investigators Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients J Am Coll Cardiol 2008;52:541-50 Gu YL, Fokkema ML, The emerging role of thrombus aspiration in the management of acute myocardial infarction Circulation 2008;118:1780-2 Fokkema ML, Vlaas PJ, Svilaas T Thrombus aspiration as definitive mechanical intervention for ST-elevation myocardial infarction: a report of five cases J Invasive Cardiol 2008:20:242-4 Geluk CA, Dikkers R, Perik PJ, Tio RA, Götte MJ, Hillege HL, Vliegenthart R, Houwers JB, Willems TP, Oudkerk M, Measurement of coronary calcium scores by electron beam computer tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease Eur Radiol 2008;18:244-52 Smit JJ, Ottervangfer JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, De Boer MJ,, Van t Hof AW; ON-TIME Study Group Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction Am J Cardiol 2008;101:446-51 Deuling JH, Vermeulen RP, Anthonio RA, Van den Heuvel AF, Jaarsma T, Jessurun GA, De Smet BJ, Tan ES, Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression Catheter Cardiovasc Interv 2008;71:518-23 Belonje AM. Voors AA, Van Gilst WH, Anker SD, Slart R.H., Tio RA., Van Veldhuisen DJ; HEBE-III investigators Effects of erythropoietin aftera n acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III) Am Heart J 2008;155:817-22 Groenewegen HC, Onuta G, Goris M, Zandvoort A,, Van Gilst WH, Rozing J, De Smet BJ, Roks AJ, Hillebrands JL Non-bone marrow origin of neointimal smoot muscle cells in experimental in-stent restenosis J Vasc Res 2008;45:493-502

How to remove thrombus prior to stenting in patients with acute myocardial infarction? Catheter Cardiovasc Interv 2008;72:204 A novel delta-protein-kinase inhibitor for adjunctive therapy during percutaneous coronary intervention Nat Clin Pract Cardiovasc Med 2008;5:446-7 Vermeulen RP, Jessurun GA, Peels HO, Jaarsma T, Clinical performance indicators for percutaneous coronary intervention. Crit Pathw Cardiol 2008;7:126-32 Dikkers R, Willems TP, Piers LH, De Jonge GJ, Tio RA, Van der Zaag-Loonen HJ, Van Ooijen PM,, Oudkerk M Coronary revascularization treatment based on dual-source computed tomography Eur Radiol 2008;18:1800-8 Vlaar PJ, Diercks GF, Svilaas T, Vogelzang M, De Smet BJ, Van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, The feasibility and safety of routine thrombus aspiration in patients with non-stelevation myocardial infarction Catheter Cardiovasc Interv 2008;72:937-42 Vogelzang M, Loef BG, Regtien JG, Van der Horst IC, Van Assen H,, Nijsten MW Computer-assisted glucose control in critically ill patients Intensive Care Med 2008;34:1421-7 Gu YL, Fokkema ML, The emerging role of thrombus aspiration in the management of acute myocardial infarction Circulation 2008;118:1780-2 Fokkema ML, Vlaas PJ, Svilaas T Thrombus aspiration as definitive mechanical intervention for ST-elevation myocardial infarction: a report of five cases J Invasive Cardiol 2008;20:242-4 Piers LH, Salachova F, Slart RH, Vliegenthart R, Dikkers R, Hospers FA, Bouma HR, Zeebregts CJ, Willems TP, Oudkerk M,, Tio RA. The role of coronary artery calcification score in clinical practice BMC Cardiovasc Disord 2008;8:38 Tan ES, Jessurun G, Deurholt W, Van der Vleuten P, Van den Heuvel A, Ebels T,, Tio R Differences between early, intermediate, and late angioplasty after coronary artery bypass grafting Crit Pathw Cardiol 2008;7:239-44 Dieperink W, Nijsten MW, Van de Stadt M, Van der Horst IC, Aarts LP,, Jaarsma T Implementation of Boussignac continuous positive airway pressure in the coronary care unit: experiences and attitudes Heart Lung 2008;37:449-54 Piers LH, Dikkers R, Willem TP, De Smet BJ, Oudkerk M,. Tio RA

Computed tomographic angiography or conventional coronary angiography in therapeutic decision-making Eur Heart J 2008;29:2902-7 Vlaar PJ, Svilaas T, Damman K, De Smet BJ, Tijssen JG, Hillege HL, Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systemic review Circulation 2008;118:1828-36 De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Adjunctive manual thrombectomy improves myocardial perfusuion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials Eur Heart J 2008;29:3002-10 De Vos AM, Rutten A, Van de Zaag-Loonen HJ, Bots ML, Dikkers R, Buiskool RA, Mali WP, Lubbers DD, Mosterd A, Prokop M, Rensing Bj, Cramer MJ, Van Es HW, Moll FL, Van de Pavoordt ED, Doevendans PA, Velthuis BK, Mackaay AF,, Oudkerk M Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trial Trials 2008;9:49 De Jonge GJ, Van Ooijen PM, Piers LH, Dikkers R, Tio RA, Willems TP, Van den Heuvel AF, Zijlstra F, Oudkerk M Visualization of anomalous coronary arteries on dual-source computed tomography Eur Radiol 2008;18:2425-32 Groen JM, Greuter MJ, Vliegenthart R, Suess C, Schmidt B,, Oudkerk M Calcium scoring using 64-slice MDCT, dual source CT and EBT: a comparative phantom study Int J Cardiovasc Imaging 2008;24:547-56

Nationale tijdschriften Van der Meer P, Van Veldhuisen DJ Nieuwe toepassingen van erytropoëtine bij cardiovasculaire aandoeningen: van hematopoëse tot cardioprotectie Ned Tijdschr Geneeskd 2008;152:923-7 Vermeulen RP, Jaarsma T, Hanenburg FG, Nannenberg JW, Jesusrun GA, Prehospital diagnosis in STEMI patients treated by primary PCI: the key to rapid reperfusion Neth Heart J 2008;16:5-9 Van der Horst ICC, Van Veldhuisen DJ Bespreking Leerboek Hartfalen, 2 e, geheel herziene druk, onder redactie van Voors AA en Kirkels JH Ned Tijdschr Geneeskd 2008;19:1127 Jaarsma T, Van der Wal MH, Lesman-Leegte I, Luttik M.L. Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, Van Gilst WH, Lok DJA, Dunselman PHJM, Hillege HL, Van Veldhuisen DJ Waarde van lichte en intensieve begeleiding van patiënten met hartfalen; resultaten van het COACH-onderzoek Ned Tijdschr Geneeskd 2008;152:2016-21 Huzen J, Van Veldhuisen DJ, Van Gilst WH, Van der Harst P Telomeren en biologische veroudering bij hart- en vaatziekten Ned Tijdschr Geneeskd 2009;152:1265-70 Aalberts JJJ, Van den Berg MP, Bergman JEH, Du Marchie Sarvaas GJ, Post JG, Van Unen H, Pals G, Boonstra PW, Van Tintelen JP The many faces of aggressive aortic pathology: Loeys-Dietz syndrome Neth Heart J 2008;16:299-304 Wijpkema JS, Anthonio RL, Jessurun GA, Wijk WA, Tio RA, Restenosis begets restenosis: implications for stent selection Neth Heart J 2008;16:376-81 Langeveld BE, Henning RH, De Smet BJ,, Driessen, Tijsma E, Van Gilst WH, Roks A Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents Neth Heart J 2008;16:291-2 Gu YL, Svilaas T, Van der Horst IC, Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention Neth Heart J 2008;16:325-31 Van der Laan A, Hirsch A, Nijveldt R, Van der Vleuten PA, Van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, Van Rossum AC, Tijssen JG,, Piek JJ Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results Neth Heart J 2008;15:436-9